Community Advisory Committee
Simons Searchlight is a partnership of leading scientists, doctors, patient advocacy leaders, clinicians, participants, and families, determined to accelerate science and improve lives for people with rare genetic neurodevelopmental disorders. As part of this mission, Simons Searchlight works with a Community Advisory Committee (CAC) whose purpose is to advise and guide research and community activities on behalf of all Simons Searchlight participants and genetic communities.
Read more about the current members below.

Johnathan Anderson
Johnathan is the parent of a 20-year-old daughter with ADNP and 15q duplication and works as an advanced clinical practitioner in the United Kingdom. This dual perspective gives him a unique view of the healthcare journey, informed by both lived experience and professional practice. He hopes to use his clinical expertise and professional networks to help guide Simons Searchlight research from both a personal and medical standpoint.

Luca Rino Belloni
Luca Belloni is a Strategic Advisor for a group of companies. He is Italian and lives in Italy with his wife, Francesca, and their three children: Tommaso (10), Giorgio (7), and Alessia (6 months). Giorgio has a mutation in the PPP2R5D gene, diagnosed at age 2 through whole exome sequencing. Since then, Luca has been deeply involved with Jordan’s Guardian Angels, working tirelessly to advance research on the disease. In 2025, with crucial support from Simons Searchlight, this research will lead to clinical trials for a potential treatment.
Luca is also dedicated to supporting families affected by the disease, both internationally and locally. In Italy, he is establishing a national branch of Jordan’s Guardian Angels to raise awareness, support families, fund research, and advocate for European approval of FDA-authorized treatments. To achieve this, Luca is collaborating with Italian institutions and encouraging the creation of similar efforts across Europe, aiming for stronger representation in European regulatory bodies.
On a global level, Luca actively engages with the international community of families, both virtually and in person. He is proud and honored to contribute to Simons Searchlight’s initiatives locally, across Europe, and worldwide.

Taylor Coach
Taylor Coach is honored to serve as a member of the Community Advisory Committee. They contribute community perspectives to support ethical, inclusive research practices and value collaboration and meaningful community involvement.

Jessica Joy Cuthbertson
Jessica Joy Cuthbertson is a Colorado native, a 1997 Boettcher Scholar, and a National Board Certified Teacher (NBCT) with 20 years of experience in the field of K-12 education. She has a passion for teaching and supporting readers across all developmental stages, especially students with dyslexia and learning challenges.
In 2019, she left the classroom to focus on caregiving and homeschooling her only son, Henok, earning her CNA and RBT licenses in the process. She also serves as an Education Coach and Homeschool Consultant with Hopkins Education Services, a locally owned tutoring company specializing in serving students with developmental and learning disabilities. She served a two-year term as an Arapahoe County representative for the Colorado Special Education Advisory Committee (CSEAC), and is a 2024 graduate of the JFK Partners LEND (Leadership Education in Neurodevelopmental Disabilities) Program. She serves as a current trained support parent and community ambassador for P2P (Parent-to-Parent) Colorado.
Jessica earned a B.A. in Communication and Sociology from Regis University and an M.A. in Education from the University of Colorado at Denver (UCD). She is a sibling to a sister with vision impairment and developmental disabilities, and the adoptive mother to a son with Coffin-Siris Syndrome (ARID1B gene variant) and related developmental disabilities. Jessica is interested in learning more about advocacy for and with the rare disease community, and supports inclusive solutions designed to build bridges of understanding between systems like law enforcement and public education and the neurodivergent individuals, families, caregivers, and communities they serve.

Sarah Davis
Sarah Davis, PhD is a sterility assurance drug reviewer for the Food and Drug Administration (FDA). She holds a PhD in microbiology from the University of Tennessee and a bachelor’s in microbiology from Clemson University. Prior to her work as a reviewer, she conducted microbial pathogenesis research for the National Institutes of Health (NIH) and later at the University of Maryland. Research at each institution has resulted in peer-reviewed scientific publications in the fields of both bacterial and fungal pathogenesis.
While attending graduate school she met her husband Steve, a microbiology postdoctoral fellow, and together they raise their young daughter Holly. At 23 months, Holly was diagnosed with autism and speech delay. Following the autism diagnosis whole exome sequencing was performed, which revealed that both Sarah and Holly carry a pathogenic variant/ mutation in the RERE gene. RERE-related neurodevelopmental disorders are associated with developmental delays, autism spectrum, and low muscle stone. As a child Sarah also had a significant speech delay, which may be explained by this mutation. The genetic sequencing results have given her family a better understanding of both Sarah’s and Holly’s childhoods. Sarah is happy to join the Simons Searchlight CAC. She resides with her family in Silver Spring, MD and is originally from Florence, SC.

Delf
Delf is a seasoned IT professional with over 20 years of experience and a passion for global cultures. Having lived and worked in countries such as the United States, Argentina, India, and the Philippines, he brings a multicultural perspective to his leadership style. He holds an MBA in Information Technology and a Bachelor of Science in Business Computer Systems.
With a background in cybersecurity, digital workplace solutions, and product management, Delf currently leads teams at a large multinational company, focusing on automation, data analytics, and user experience. He has a proven track record in delivering enterprise-scale solutions and driving innovation.
Delf’s approach is defined by his core strengths: as a Relator, he excels at building meaningful connections; as a Maximizer, he brings out the best in people and projects; his Analytical mindset enables him to break down complexities, and his Achiever drive ensures he meets and surpasses goals.
Married to a Brazilian, Delf is a proud husband and a hands-on dad to his nine-year-old daughter. He enjoys balancing his career with family life, fostering creativity, having fun, and exploring the world together.

Melissa Dye
Melissa is honored to serve on the Simons Searchlight Community Advisory Committee as both a parent and an advocate. Her son has a de novo GIGYF1 gene mutation, and he was diagnosed with Asperger’s at age five. That diagnosis didn’t define him, but it helped them fight for the support he deserved. She spent years advocating to keep him in mainstream classes and pushing through school systems that often struggled to understand him. With the right support, he thrived — graduating summa cum laude with technical honors and ranking in the top five percent of his class.
Before this journey, Melissa worked in an adolescent psychology treatment facility, which gave her a strong foundation in understanding behavior, neurodiversity, and family systems. Combined with her lived experience, it has allowed her to help many families navigate school challenges, advocate for their children’s educational needs, and push back when systems fall short.
As part of the Community Advisory Committee, her goal is to amplify family perspectives, strengthen communication between researchers and caregivers, and support a future where families feel seen, informed, and empowered as they navigate rare genetic conditions.

Amy Fields
Amy Fields adopted two children with rare conditions out of foster care. Her oldest has the KME2E mutation. When he was diagnosed, there was little information available. Amy joined up with other parents in the KMT2E community and formed a group to provide education, connections, and hope.
Amy is a teacher and advocate. She served on the FAC at Children’s Hospital in MN where she focused on patient centered care, bereavement, and helped rewrite educational materials to make them more family friendly. Currently Amy is working for The Lucas Project, a non-profit organization that supports parent caregivers. In her spare time Amy enjoys spending time with her family, reading about Tudor history, and enjoying long Minnesota winters.

Michelle Gamble
Michelle Gamble, lives in Leicestershire, England with her husband and is a proud mother to three children, aged 21,17 and 7.
Their youngest child was diagnosed aged three with a rare genetic syndrome VPS13B – Cohen Syndrome. She has complex care needs, learning disabilities and Autism. Michelle was a dedicated registered adult nurse, graduating from Demontfort University in Leicester. She worked for many years on hospital wards and moved onto work as a nurse consultant, assisting community care settings with compliance. For the last eight years Michelle has been working as an early year practitioner, she runs a pre-school setting with her husband and oldest son for children aged 0-5, many of whom have a wide variety of additional needs.
Michelle is excited to join Simons Searchlight’s CAC, with her professional background in healthcare, early years education and her personal experience as a parent carer, she brings a unique and compassionate perspective to the role.

Joe Henry
A severe case of dyslexia has had an unexpected silver lining for Joe Henry, teaching him to find creative ways to navigate obstacles. Over the years, doctors diagnosed his son Franklin with one condition after another, and at various times Joe was told he was the father of a child with oppositional defiant disorder, autism, Tourette syndrome, and more. When Franklin was 25, genetic testing through SPARK for Autism revealed the underlying cause: NR4A2-related syndrome.
Joe played a key role in securing a National Organization for Rare Disorders (NORD) listing for NR4A2 and has connected with researchers around the world studying the condition. After reaching out to a researcher at UCLA, these efforts led to a new study using Franklin’s cells. Joe has also shared his story as a guest on Effie Parks’ podcast.
For the first 18 years of Franklin’s life, Joe and his wife never spent a night away together without their children. He has deep empathy for families navigating disability, especially those doing so without a clear diagnosis. Joe is very active in a Facebook group for families affected by NR4A2-related syndrome, where he offers encouragement, information, and support. One of his favorite sayings reflects his outlook: “I used to feel bad that I had no shoes until I met the man who had no feet.”

Ross Kenyon
Ross Kenyon is the adoptive parent of a son with a rare genetic disorder. With a background in climate technologies and fostering early-stage ventures, Ross has developed a unique skill set in translating complex ideas and supporting impactful initiatives. He has worked across diverse sectors, including carbon removal, regenerative agriculture, and financial innovation, always with an eye toward creating meaningful change.
Joining the Simons Searchlight Community Advisory Committee, Ross is passionate about advancing research and building community support for individuals with genetic neurodevelopmental disorders.

Keith McArthur
Keith McArthur is the co-founder and Executive Director of the CureGRIN Foundation and the father of Bryson, a teenager living with GRIN1 Disorder. A published author and seasoned communicator, Keith is the creator and host of Unlocking Bryson’s Brain, a CBC-produced podcast chronicling his family’s journey from a mysterious diagnosis to the frontiers of genetic research. His professional background includes a career as a newspaper reporter and a tenure as Vice President of Social Media at the telecommunications leader Rogers Communications.
At CureGRIN, Keith translates his expertise in senior leadership and advocacy into a rigorous search for treatments and cures for GRI Disorders. He has been the driving force behind the foundation’s “Cure Roadmap,” a strategic framework designed to accelerate the transition from foundational science to clinical trials. Under his leadership, CureGRIN has successfully deployed nearly $1 million in research funding, positioning the foundation as a global catalyst for life-changing medical breakthroughs.

Jessica McHugh
Jessica McHugh, MPH, is an epidemiologist at a local public health agency in Missouri, where she focuses on community health data, substance use, and overdose prevention. She completed both her undergraduate and Master of Public Health degrees at Saint Louis University. Jessica has worked in public health for over 10 years and enjoys a good spreadsheet just as much as a community coalition meeting.
Jessica lives with her husband and two children in St. Louis, Missouri, where they are navigating a diagnosis of CSNK2B neurodevelopmental disorder for their youngest child. Genetic testing following the onset of seizures in July 2024 identified the gene mutation underlying the diagnosis and, like many parents of children with rare diseases, prompted a deep dive into the published literature on CSNK2B and related conditions.

Alberta McWilliams
Alberta lives on the North Coast of Northern Ireland and works within the Northern Ireland Civil Service as a Staff Officer in the Department for Infrastructure (2001 to present). Her various roles have allowed her to gain valuable skills in presentation, communication, working collaboratively, analysis and critical thinking.
Alberta is the proud mother of b/g twins, Ada & Thom, who were born in April 2016 prematurely. Ada had a very low birth weight (3.5lbs) and a difficult journey followed through the next few years. Ada received a genetic diagnosis of CUL-3 related neurodevelopmental disorder in February 2023 which was both a shock but also a comfort in that the difficulties experienced could now be put into context.
Alberta is looking forward to participating fully in CAC to help find solutions and to strive for progress. She hopes to help other families who find themselves in a similar position.

Kaitlin Miller
Kaitlin Miller, MSN, MBA, RN is Director of Clinical Quality at OneOncology where she overseas a Qualified Clinical Data Registry as well as performance in governmental and commercial value-based care programs. She is a dedicated healthcare professional with over 13 years of professional experience with a deep commitment to driving innovation in healthcare through improvement in quality of patient care and increased access. With a strong background in clinical operations and strategic planning, Kaitlin has spent years working to enhance outcomes for patients with chronic conditions and a deep passion for providing care in the community, keeping patients out of the hospital and enabling more days spent at home.
Kaitlin‘s eldest child was diagnosed in 2024 at the age of 10 with NAA15 syndrome through the Simons foundation Spark study for autism after enrolling in 2019 when standard care had little to offer. This personal experience combined with a deep understanding of the healthcare systems and payer programs has inspired a new passion for advocacy in research and healthcare solutions for those affected by rare disease. She regularly works with local providers on the benefits and process of becoming enrolled with children’s long term support services to increase access for therapeutic and recreational activities within the community for families and children effected by rare disease and disability. She is excited to be joining the Community Advisory Council as she begins her journey in understanding the rare disease space and finding where she can help make a difference.
Kaitlin holds dual Master’s degrees in Nursing Administration and Business Administration from Kent State University, along with a Bachelor of Science in Nursing.

Erin Morgan
Erin Morgan is a dedicated advocate for individuals impacted by rare diseases, driven by her personal experience as a mother of a daughter diagnosed with IRF2BPL-Related Disorder in 2024. Her journey began with a profound desire to make a difference, leading her and her husband to establish a nonprofit organization called Tough Genes, focused on raising awareness and funding research to improve the lives of those affected by IRF2BPL mutations.
As a member of the Simons Searchlight Community Advisory Committee, Erin brings a current perspective of the struggles and life altering effects of a rare diagnosis. Her personal experience, combined with her dedication, drives her ongoing efforts to shine a spotlight on these challenges faced by rare disease patients and their families. She is excited to work alongside other rare disease leaders to continue to improve Simons Searchlight and ensure that the information is both accessible and relevant to patient communities and researchers.
Erin has a professional background in Human Resources. Her passion for helping others, effective communication and solving problems in the workplace brings a valuable skill set to the rare disease space. She is committed to advancing scientific knowledge and medical understanding of ultra rare genetic disorders while supporting and uplifting patients and families. Every family deserves answers, every patient deserves treatment.

Victoria Powell
Dr. Powell is an assistant professor at the University of Michigan in the division of Geriatric and Palliative Medicine. She is also a research investigator and staff physician at the LTC Charles S. Kettles VA Medical Center in Ann Arbor, MI.
Her research interests include novel approaches to treatment for people living with chronic pain and complex psychosocial and existential distress states, such as loneliness and demoralization. She is principal or co-investigator on multiple clinical trials involving pharmacologic, behavioral, and combined interventions. She completed internship and residency in internal medicine at Johns Hopkins Hospital, followed by a clinical fellowship in hospice and palliative medicine at the NIH Clinical Center. In 2024, her son was diagnosed with 17p13.3 microduplication syndrome.

Genesis Romo-Raudry
Genesis is the mother of a beautiful boy with CNOT3. She holds a master’s degree in Special Education from the University of Illinois at Chicago. After earning her degree, she chose to put her career on hold to be with her children during their most formative years. This allows her to pick up her little one from school and take him to his therapies, providing opportunities to directly communicate with his teachers and therapists to implement strategies at home.
Genesis enjoys doing art and crafts with her children and has a passion for creating bucket lists. She advocates for mothers seeking answers outside the box, understanding the loneliness that can accompany this journey. She believes that by sticking together, families can find answers and knowledge collaboratively.

Victoria Schaible
Victoria Schaible is a Board-Certified Behavior Analyst (BCBA) residing in Virginia. Victoria obtained her undergraduate degree from Longwood University with a major in psychology in 2014, and her master’s degree in special education with a concentration in Applied Behavior Analysis (ABA) from George Mason University in 2019. Victoria has worked with children on the autism spectrum for 8 years and has been a Board-Certified Behavior Analyst for 4 years.
Victoria was introduced to the world of rare genetic disorders in the fall of 2023 when her son was diagnosed with Wiedemann-Steiner Syndrome. This genetic condition affects the KMT2A gene. Since her son’s diagnosis, Victoria has sought to immerse herself into learning more about rare genetic conditions and using her background and knowledge to provide education regarding Wiedemann-Steiner Syndrome, along with rare genetic disorders to others.

Stuart Spielman
Stuart Spielman has enjoyed a long career as a lawyer and advocate. He joined Autism Speaks in 2008 and led the organization’s nationwide advocacy from 2018 until assuming senior adviser status in 2024 prior to retiring.
As a parent advocate, Stuart played a pivotal role in developing Maryland’s Home and Community-Based Services Waiver for Children with Autism Spectrum Disorder, the nation’s first Medicaid waiver for children with autism. During Stuart’s tenure, Autism Speaks worked to ensure people with autism and their families accessed needed services and supports. Stuart contributed to important initiatives including:
- The Autism Collaboration, Accountability, Research, Education, and Support Acts of 2014, 2019, and 2024 (Autism CARES) and earlier laws that authorize autism research, data collection, and training. Funding under these federal laws exceeds $5 billion.
- Improved health insurance benefits for autism through the Federal Employees Health Benefits Program.
- The Stephen Beck, Jr., Achieving a Better Life Experience Act of 2014 (ABLE), which allows people with disabilities to save money in special investment accounts without losing government benefits such as Medicaid or Supplemental Security Income (SSI).
Stuart holds a Juris Doctor degree from the University of Wisconsin School of Law and a Masters of Laws in Taxation from the New York University School of Law. He and his wife Mona have two adult sons, one of whom is on the autism spectrum.

Braxton Webb
Braxton is a 40-year-old man born and raised in Milwaukee, WI. With over 10 years of experience in the pediatric mental health field, he has dedicated his career to working with children diagnosed with autism and other behavioral and mental health issues. He has also had the privilege of working with many children diagnosed with rare genetic disorders.
A US Marine Corps veteran and former sheriff deputy, Braxton is deeply committed to serving others. He is also a proud father of two children with special needs, an experience that has shaped his perspective and work. Outside of his professional life, Braxton enjoys traveling and has a passion for playing video games, with a collection of over 300 titles. Additionally, he is highly skilled at fixing electronics and computers, often using his technical expertise to help others.

Claire Whitehill
Claire lives in Windsor UK with her husband and 4 children. Her youngest daughter Kirsty was diagnosed with Okur Chung Neuro Developmental Syndrome in 2019 as a result of being part of the 100,000 Genomes Project. Claire is a member of the CSNK2A1 Parent Advisory Board and is also the UK Regional Ambassador. Claire is a member of the Genomics England Participant Panel and of the NHS South East Genomic Medicine Service People and Communities Forum. Claire has worked as an Executive Assistant in investment banking for 12 years and before that worked in international development for 17 years. She has a degree in International Studies.